AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35802667 — intervention group
Group type: COMPARATOR
Intervention: Everolimus
Number of subjects: 232
Study 34928990 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab (900 mg doses, two doses)
Number of subjects: 75
Study 34928990 — intervention group
Group type: COMPARATOR
Intervention: Control (standard therapy)
Number of subjects: 75
Study 34928990 — intervention group
Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 75
Study 34928990 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study 34387823 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise for 6 weeks
Number of subjects: 101
Study 34387823 — intervention group
Group type: COMPARATOR
Intervention: Personalized diabetes diet intervention, online education, and routine prenatal care (Control)
Number of subjects: 101
Study 34387823 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 101
Study 32365359 — intervention group
Group type: EXPERIMENTAL
Intervention: RHB-105 (amoxicillin, 3 g; omeprazole, 120 mg; and rifabutin, 150 mg)
Number of subjects: 455
Study 32365359 — intervention group
Group type: COMPARATOR
Intervention: Active comparator (amoxicillin, 3 g, and omeprazole, 120 mg)
Number of subjects: 455
Study 32365359 — intervention group
Group type: EXPERIMENTAL
Intervention: RHB-105
Number of subjects: 455
Study 32365359 — intervention group
Group type: COMPARATOR
Intervention: Active comparator
Number of subjects: 455
Study 33899589 — intervention group
Group type: EXPERIMENTAL
Intervention: ePRO group (continuous electronic patient-reported outcomes at home)
Number of subjects: 102
Study 33899589 — intervention group
Group type: EXPERIMENTAL
Intervention: ePRO group
Number of subjects: 102
Study 33899589 — intervention group
Group type: COMPARATOR
Intervention: paper-based group (standard practice)
Number of subjects: 102
Study 34431601 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal genomic educational testing (PGET)
Number of subjects: 233
Study 34431601 — intervention group
Group type: COMPARATOR
Intervention: No personal genomic educational testing (NPGET)
Number of subjects: 233
Study 32511110 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week home-based telehealth exercise training program
Number of subjects: 50
Study 32511110 — intervention group
Group type: COMPARATOR
Intervention: Usual lifestyles (control group)
Number of subjects: 50
Study 34344171 — intervention group
Group type: EXPERIMENTAL
Intervention: FitBit + SparkPeople
Number of subjects: 44
Study 34344171 — intervention group
Group type: COMPARATOR
Intervention: FitBit only
Number of subjects: 44
Study 34344171 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring, goal setting, and self-efficacy
Number of subjects: 44
Study 32039737 — intervention group
Group type: EXPERIMENTAL
Intervention: Biopsychosocial paediatric-adult transition programme (Arm B)
Number of subjects: 0
Study 32039737 — intervention group
Group type: COMPARATOR
Intervention: Control group (Arm A)
Number of subjects: 0
Study 33658686 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 148
Study 33658686 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 148
Study 32707289 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal hypopressive technique (AHT) programme for 2 months
Number of subjects: 42
Study 32707289 — intervention group
Group type: COMPARATOR
Intervention: Rest for 2 months
Number of subjects: 42
Study 35184691 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose intravenous cefuroxime after cord clamping (n=19)
Number of subjects: 40
Study 35184691 — intervention group
Group type: COMPARATOR
Intervention: Single dose intravenous cefuroxime 30 minutes before skin incision (n=21)
Number of subjects: 40
Study 34516712 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted MIS-TLIF
Number of subjects: 48
Study 34516712 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 48
Study 32524118 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic scaling for 60 seconds on crowns cemented with resin modified glass cement
Number of subjects: 48
Study 32524118 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic scaling for 60 seconds on crowns cemented with resin cement
Number of subjects: 48
Study 32524118 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of micro-leakage between zirconia crown and glass-ceramic crown with or without ultrasonic scaling
Number of subjects: 48
Study 35481572 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (25 mg twice daily)
Number of subjects: 28
Study 35481572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 34721414 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone stimulation
Number of subjects: 0
Study 34721414 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CD4+ Ki-67 and FKBP51 expression
Number of subjects: 0
Study 34721414 — intervention group
Group type: COMPARATOR
Intervention: Comparison of FKBP51 expression in CD8+ T cells and CD19+ B cells
Number of subjects: 0
Study 34721414 — intervention group
Group type: COMPARATOR
Intervention: Polarization profiles for Th1, Th2, Th9, or Th17 percentage
Number of subjects: 0
Study 35811518 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized, precision medicine protocol for nine months
Number of subjects: 25
Study 35811518 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI volumetrics
Number of subjects: 25
Study 33440446 — intervention group
Group type: EXPERIMENTAL
Intervention: VAR group (different exercises)
Number of subjects: 22
Study 33440446 — intervention group
Group type: COMPARATOR
Intervention: N-VAR group (same exercises)
Number of subjects: 22
Study 32381031 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of an algorithm for early detection and minimally invasive management of pancreatic fistula
Number of subjects: 1600
Study 32381031 — intervention group
Group type: COMPARATOR
Intervention: Current practice
Number of subjects: 1600
Study 35311446 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-fiber bread (150 g daily, enriched with a 7-dietary fiber mixture providing 16.05 g of fibers)
Number of subjects: 39
Study 35311446 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-fiber bread
Number of subjects: 39
Study 35311446 — intervention group
Group type: COMPARATOR
Intervention: Control bread (standard bread, 150 g daily)
Number of subjects: 39
Study 32554133 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based cognitive training video game (Aquasnap) for 6 months, at least 3 times a week for a minimum of 60 minutes per week, in addition to standard care
Number of subjects: 46
Study 32554133 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention group received standard care for 3 months followed by 3 months of MyCQ training
Number of subjects: 46
Study 34391239 — intervention group
Group type: EXPERIMENTAL
Intervention: Miofascial Release (MFR) applied for 3min
Number of subjects: 51
Study 34391239 — intervention group
Group type: EXPERIMENTAL
Intervention: Miofascial Release (MFR) applied for 5min
Number of subjects: 51
Study 34391239 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (non-therapeutic gel with light touch for 3min)
Number of subjects: 51
Study 32194094 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene and Vitamin D in nanostructure lipid carriers (NLCs)
Number of subjects: 0
Study 32194094 — intervention group
Group type: COMPARATOR
Intervention: Commercial product
Number of subjects: 0
Study 34743663 — intervention group
Group type: EXPERIMENTAL
Intervention: modified constraint‐induced movement therapy (mCIMT)
Number of subjects: 30
Study 34743663 — intervention group
Group type: EXPERIMENTAL
Intervention: bimanual training (BIM)
Number of subjects: 30
Study 34446763 — intervention group
Group type: EXPERIMENTAL
Intervention: High cognitive functioning group (14 patients, 15%)
Number of subjects: 94
Study 34446763 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium cognitive functioning group (58 patients, 62%)
Number of subjects: 94
Study 34446763 — intervention group
Group type: EXPERIMENTAL
Intervention: Low cognitive functioning group (22 patients, 23%)
Number of subjects: 94
Study 34446763 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively impaired patients at baseline (52 patients, 55%)
Number of subjects: 94
Study 34446763 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with the poorest cognitive function
Number of subjects: 94
Study 34446763 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact on activities of daily living
Number of subjects: 94
Study 32568452 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 80
Study 32568452 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 80
Study 35614486 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-guided SBRT starting at 10 × 5.5 Gy, escalating up to 10 × 6.5 Gy
Number of subjects: 38
Study 34421016 — intervention group
Group type: EXPERIMENTAL
Intervention: text4FATHER intervention
Number of subjects: 0
Study 34879902 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 224
Study 34879902 — intervention group
Group type: EXPERIMENTAL
Intervention: OSA+insomnia
Number of subjects: 224
Study 34879902 — intervention group
Group type: COMPARATOR
Intervention: OSA
Number of subjects: 224
Study 35614564 — intervention group
Group type: EXPERIMENTAL
Intervention: multimedia-based assent document
Number of subjects: 116
Study 35614564 — intervention group
Group type: COMPARATOR
Intervention: paper-based assent document
Number of subjects: 116
Study 33532013 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg amitriptyline at bedtime
Number of subjects: 80
Study 33532013 — intervention group
Group type: COMPARATOR
Intervention: 5 mg amitriptyline at bedtime
Number of subjects: 80
Study 32315958 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/d of sodium butyrate (NaBut)
Number of subjects: 60
Study 32315958 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g/d of high‐performance (HP) inulin
Number of subjects: 60
Study 32315958 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/d of sodium butyrate + 10 g/d of HP inulin
Number of subjects: 60
Study 32315958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34215548 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33772794 — intervention group
Group type: EXPERIMENTAL
Intervention: LSD
Number of subjects: 0
Study 33772794 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 0
Study 33772794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35546101 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact fish skin grafts (FSGs)
Number of subjects: 51
Study 35546101 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 51
Study 33262022 — intervention group
Group type: EXPERIMENTAL
Intervention: Red cell transfusion
Number of subjects: 270
Study 33262022 — intervention group
Group type: COMPARATOR
Intervention: Not transfused
Number of subjects: 270
Study 33722585 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent high-dose influenza vaccine (QIV-HD)
Number of subjects: 120000
Study 33722585 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose quadrivalent influenza vaccine (QIV-SD)
Number of subjects: 120000
Study 32941349 — intervention group
Group type: EXPERIMENTAL
Intervention: TEG/ROTEM-guided blood transfusions
Number of subjects: 0
Study 32941349 — intervention group
Group type: COMPARATOR
Intervention: Traditional coagulation parameters
Number of subjects: 0
Study 34224987 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin administered intravenously to keep arterial blood glucose between 6 and 8 mmol/l during surgery
Number of subjects: 18
Study 34224987 — intervention group
Group type: COMPARATOR
Intervention: Control group received insulin if blood glucose >11.5 mmol/l
Number of subjects: 18
Study 34224987 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study 34224987 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin control
Number of subjects: 18
Study 32644915 — intervention group
Group type: EXPERIMENTAL
Intervention: Days with rAAA
Number of subjects: 717
Study 32644915 — intervention group
Group type: COMPARATOR
Intervention: Control days
Number of subjects: 717
Study 35422497 — intervention group
Group type: EXPERIMENTAL
Intervention: Water chlorination
Number of subjects: 130
Study 36541222 — intervention group
Group type: COMPARATOR
Intervention: Arm A - Lip and soft palate closure at 3-4 months followed by hard palate closure at 12 months
Number of subjects: 431
Study 36541222 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B - Lip and soft palate closure at 3-4 months, hard palate closure at 36 months
Number of subjects: 431
Study 36541222 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm C - Lip closure at 3-4 months, hard and soft palate closure at 12 months
Number of subjects: 431
Study 36541222 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm D - Lip closure at 3-4 months, single-layer closure of hard palate using a vomer flap, soft palate closure at 12 months
Number of subjects: 431
Study 33895306 — intervention group
Group type: EXPERIMENTAL
Intervention: All-suture suture anchor (ASSA)
Number of subjects: 18
Study 33895306 — intervention group
Group type: COMPARATOR
Intervention: Conventional interference screw (CIS)
Number of subjects: 18
Study 33895306 — intervention group
Group type: COMPARATOR
Intervention: Comparison between ASSA and CIS
Number of subjects: 18
Study 32410684 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex education program (two 90-min sessions)
Number of subjects: 80
Study 32410684 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 36181316 — intervention group
Group type: EXPERIMENTAL
Intervention: PegIFN‐α monotherapy (180 μg/week)
Number of subjects: 260
Study 33633016 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Phentolamine mesylate ophthalmic solution (PMOS)
Number of subjects: 31
Study 33633016 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Phentolamine mesylate ophthalmic solution (PMOS) in the tropicamide subgroup
Number of subjects: 31
Study 33633016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 36141895 — intervention group
Group type: EXPERIMENTAL
Intervention: Climbing exercise (n = 27)
Number of subjects: 60
Study 36141895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking exercise (n = 23)
Number of subjects: 60
Study 36141895 — intervention group
Group type: COMPARATOR
Intervention: Control condition (social contact, n = 23)
Number of subjects: 60
Study 33202447 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1155
Study 33202447 — intervention group
Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 1155
Study 36090843 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-development of activities to tackle substance use
Number of subjects: 880
Study 36090843 — intervention group
Group type: COMPARATOR
Intervention: Control group participation in activities
Number of subjects: 880
Study 34726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate neoadjuvant instillation of chemotherapy (INAIC) with mitomycin C before TURBT (Group A)
Number of subjects: 124
Study 34726625 — intervention group
Group type: COMPARATOR
Intervention: Control group with TURBT only (Group B)
Number of subjects: 124
Study 32366224 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream (2 g applied to the tracheal tube cuff)
Number of subjects: 0
Study 32366224 — intervention group
Group type: COMPARATOR
Intervention: Control group (Vaseline 2 g applied to the tracheal tube cuff)
Number of subjects: 0
Study 32366224 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream
Number of subjects: 0
Study 32366224 — intervention group
Group type: COMPARATOR
Intervention: Control group (Vaseline)
Number of subjects: 0
Study 34596367 — intervention group
Group type: EXPERIMENTAL
Intervention: Anlotinib 12 mg/day
Number of subjects: 42
Study 34596367 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 32354228 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month DAPT
Number of subjects: 2712
Study 32354228 — intervention group
Group type: EXPERIMENTAL
Intervention: PRECISE-DAPT score
Number of subjects: 2712
Study 33461937 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram using a four-marker signature (CA19-9, CA125, CA50, CA242)
Number of subjects: 558
Study 33461937 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model
Number of subjects: 558
Study 33461937 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaplan-Meier survival analysis
Number of subjects: 558
Study 33190804 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 36253987 — intervention group
Group type: EXPERIMENTAL
Intervention: Wuwei Fuzheng Yijing Decoction (WWFZYJ)
Number of subjects: 66
Study 36253987 — intervention group
Group type: COMPARATOR
Intervention: Coenzyme Q10 tablets combined with vitamin E soft capsules
Number of subjects: 66
Study 34380375 — intervention group
Group type: EXPERIMENTAL
Intervention: Underwater posterior nasal neurectomy with submucous inferior turbinectomy
Number of subjects: 43
Study 34380375 — intervention group
Group type: COMPARATOR
Intervention: Resection of peripheral branches of posterior nasal nerve with turbinoplasty (Control group)
Number of subjects: 43
Study 32795875 — intervention group
Group type: EXPERIMENTAL
Intervention: 70-gene signature (MammaPrint®) guided treatment strategy
Number of subjects: 1497
Study 32795875 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment alone
Number of subjects: 1497
Study 35756497 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized nutritional intervention
Number of subjects: 100
Study 35756497 — intervention group
Group type: COMPARATOR
Intervention: Conventional nursing
Number of subjects: 100
Study 34709369 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose CT of the chest
Number of subjects: 171
Study 34709369 — intervention group
Group type: COMPARATOR
Intervention: CXR
Number of subjects: 171
Study 35552709 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine and dexamethasone every 4 weeks
Number of subjects: 150
Study 35552709 — intervention group
Group type: COMPARATOR
Intervention: Vincristine and dexamethasone every 12 weeks
Number of subjects: 150
Study 35552709 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxy-reported outcomes
Number of subjects: 150
Study 32663386 — intervention group
Group type: EXPERIMENTAL
Intervention: 830 mg CF (CF830)
Number of subjects: 23
Study 32663386 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,245 mg CF (CF1245)
Number of subjects: 23
Study 32663386 — intervention group
Group type: COMPARATOR
Intervention: 0 mg CF (Control)
Number of subjects: 23
Study 32663386 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Control and CF1245
Number of subjects: 23
Study 34664357 — intervention group
Group type: EXPERIMENTAL
Intervention: FCL plus topical tazarotene 0.1% gel
Number of subjects: 27
Study 34664357 — intervention group
Group type: COMPARATOR
Intervention: Topical tazarotene 0.1% gel only
Number of subjects: 27
Study 34776135 — intervention group
Group type: EXPERIMENTAL
Intervention: VMO facilitatory kinesio taping
Number of subjects: 32
Study 34776135 — intervention group
Group type: COMPARATOR
Intervention: VL inhibitory kinesio taping
Number of subjects: 32
Study 32580535 — intervention group
Group type: EXPERIMENTAL
Intervention: School closing (Scenario I)
Number of subjects: 9000
Study 32580535 — intervention group
Group type: COMPARATOR
Intervention: School opening after April 6 (Scenario II)
Number of subjects: 9000
Study 32580535 — intervention group
Group type: EXPERIMENTAL
Intervention: School opening after April 6 and mean period from symptom onset to hospitalization increasing to 4.3 days (Scenario III)
Number of subjects: 9000
Study 36177965 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted surgery using Preceyes Surgical System (PSS)
Number of subjects: 15
Study 36177965 — intervention group
Group type: COMPARATOR
Intervention: Manual surgery
Number of subjects: 15
Study 33980315 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing + opioid and related risk prevention services
Number of subjects: 240
Study 33980315 — intervention group
Group type: COMPARATOR
Intervention: Opioid and related risk prevention services alone
Number of subjects: 240
Study 32486583 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of levosimendan (0.1 μg·kg(‐1)·min(‐1) for 24 h after loading with 6 μg/kg)
Number of subjects: 32
Study 32486583 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance dose of levosimendan (same schedule without loading dose)
Number of subjects: 32
Study 32486583 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 32
Study 35288394 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaemia (severe, moderate, mild)
Number of subjects: 2023
Study 35288394 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaemia (severe to moderate)
Number of subjects: 2023
Study 35288394 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaemia
Number of subjects: 2023
Study 32876732 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual atropine (600-μg dose)
Number of subjects: 21
Study 32876732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 35869311 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated beetroot juice (BJ) 24 ml daily for 12 weeks
Number of subjects: 46
Study 35869311 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 35869311 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated beetroot juice (BJ)
Number of subjects: 46
Study 34463946 — intervention group
Group type: EXPERIMENTAL
Intervention: LOFF-LESS (gasless laparoscopic operation field formation device)
Number of subjects: 100
Study 34463946 — intervention group
Group type: COMPARATOR
Intervention: LESS (conventional CO2 pneumoperitoneum)
Number of subjects: 100
Study 36438250 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Training (CT) program (16 weeks of resistance and aerobic exercise)
Number of subjects: 31
Study 36438250 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-exercise)
Number of subjects: 31